aminoimidazole carboxamide has been researched along with Cystic Fibrosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Barraja, P; Barreca, M; Cilibrasi, V; Galietta, LJV; Genovese, M; Montalbano, A; Renda, M; Spanò, V | 1 |
Baty, CJ; Fitch, AC; Hallows, KR; King, JD; Kolls, JK; Magill, A; Myerburg, MM; Oyster, NM; Pilewski, JM; Watkins, SC | 1 |
2 other study(ies) available for aminoimidazole carboxamide and Cystic Fibrosis
Article | Year |
---|---|
Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein.
Topics: Aminoimidazole Carboxamide; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Mutant Proteins; Mutation; Protein Folding; Thiazoles | 2021 |
AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Anti-Inflammatory Agents; Cell Polarity; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Cytokines; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Epithelial Cells; Epithelial Sodium Channels; Humans; Inflammation Mediators; Membrane Potentials; Metformin; Microscopy, Confocal; Pneumonia; Respiratory Mucosa; Ribonucleotides; Sodium; Time Factors; Water-Electrolyte Balance | 2010 |